Waters BioResolve RP mAb Polyphenyl Columns, setting a new standard for reversed-phase separations of Monoclonal Antibodies and Antibody Drug Conjugates
Waters Corporation (NYSE:WAT) today introduced BioResolve™ RP mAb Polyphenyl 450 angstrom 2.7 micron solid core Columns intended for the reversed-phase analysis of intact or sub-unit-digested monoclonal antibodies (mAbs) and antibody-drug conjugates (ADCs) using LC-UV and LC-MS...